Tafenoquine

Tafenoquine (CAS No.: 106635-80-7) is a synthetic small molecule of the 8 aminoquinoline class that is primarily categorized in anti infectious and antiparasitic research as a blood and tissue stage antiplasmodial probe, and it is widely used in biomedical discovery programs to investigate parasite redox vulnerability, mitochondrial homeostasis, and stage specific susceptibility in Plasmodium systems; current mechanistic understanding indicates a multi process mode of action rather than a single highly selective protein target, with evidence consistent with intracellular bioactivation linked to oxidative stress, disruption of parasite metabolic balance, and downstream impairment of schizont development, while pathway level studies commonly examine redox associated networks and mitochondrial function readouts in host erythrocyte parasite culture platforms; across in vitro assays, activity is generally reported in the nanomolar to low micromolar range depending on parasite species, lifecycle stage, strain background, and assay format, and the compound is therefore frequently incorporated as a reference or comparator in phenotypic screening workflows, resistance profiling, and combination design studies; in translational preclinical settings it is also used in animal malaria models and in mechanistic investigations related to hemolytic liability and erythrocyte stress biology to support safety relevant hypothesis testing, with concentrations or doses in experiments typically determined by specific study design, model system characteristics, and research objectives, and all use is restricted to controlled laboratory research contexts and not for human consumption or non research applications.